Welcome to International Society for Vaccines
Mark K. Slifka
Dr. Mark K. Slifka earned his B.S. degree in microbiology and molecular biology in 1992 from Washington State University from the UCLA School of Medicine with a Ph.D. in microbiology and immunology in 1996, Mark Slifka became a postdoctoral fellow in the department of neuropharmacology at the Scripps Research Institute in La Jolla. He came to OHSU as an assistant professor and to ONPRC as an affiliate assistant scientist in 2001 and was promoted to associate professor and associate scientist in 2006. Slifka was promoted to professor in 2011 and to senior scientist in 2013. PhD at the UCLA School of Medicine and currently holds a joint faculty position as a Professor of Molecular Microbiology and Immunology at Oregon Health & Science University and Senior Scientist at the Oregon National Primate Research Center. Dr. Slifka also serves as President and CSO of Najít Technologies, Inc. Dr. Slifka sets expansive goals for NTI’s vaccine development pipeline, identifying significant target pathogens and engaging a talented group of partners to advance these important vaccine programs. Dr. Slifka has published >80 research articles and reviews, including papers in prestigious biomedical journals. He has been quoted in >200 news articles. Dr. Slifka has served on academic review panels for both governmental and private institutions.